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In order to test if retinoic acid-mediated differenti-
ation of embryoid bodies can be used as an in vitro
preselection method for ES cell lines generated by
gene trap, we correlated gene expression after in vitro
differentiation and in 11.5-day embryos. Fifty-two
genes captured by gene trap and expressed in undif-
ferentiated embryonic stem cells were analyzed. Most
genes expressed after differentiation in vitro were also
expressed during embryo development. In order to
correlate the expression patterns in vitro and in vivo,
the in vitro expression in the center and in the periph-
ery of the embryoid body outgrowths was observed.
This allowed us to distinguish, according to in vitro
expression, not expressed genes from those expressed
widely in 11.5-day embryos. Consequently, with this
parameter we increased the probability to obtain the
restricted expression patterns in vivo. This study dem-
onstrates the potential of the differentiation proce-
dure in combination with the gene trap to select in
vitro for genes expressed during embryo development.
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INTRODUCTION
Embryonic stem (ES) cells posses an extraordinary
ability to contribute to embryo development and to gen-
erate, via germ cells, a complete animal [1]. Conse-
quently, ES cells are genetically modified in culture, and
animals carrying this genetic modification are generated.
This technique is mainly used for targeted mutagenesis
by homologous recombination [2]. In contrast to this spe-
cific approach, the ES cell genome can be randomly al-
tered by inserting a nonhomologous construct, a method
referred as gene trap [3, 4]. In this way a previously
unknown gene can be tagged and subsequently analyzed
[5]. However, not every trapped gene will be interesting
and therefore the procedure includes a tedious selection
process. The predominant rationale is that the genes
expressed in a restricted manner during embryo devel-
opment are more likely to have a control function, and,
when mutated, to generate changes of phenotype. This
implies selection of gene trap insertions after producing a
chimeric animal and a subsequent analysis of the expres-
sion pattern of the trapped gene in vivo [6]. As this
requires vast resources and number of animals, a sub-
stantial effort is being made to modify the random screen
in order to get genes of particular interest. One of the
possible solutions, termed ‘‘in vitro preselection,’’ at-
tempts by analyzing in vitro differentiated ES cells to
predict genes expressed in corresponding differentiated
tissues in vivo [7, 8].
In order to test if the retinoic acid (RA)-mediated
differentiation of ES-cell-derived embryoid bodies can
be used as an in vitro preselection method for gene
trap, we performed a large scale screen comparing the
gene expression patterns in vitro and in vivo. The
applied differentiation procedure has already been
shown to generate neurons and glia and to mediate the
expression of Pax6, a developmentally regulated tran-
scription factor expressed during central nervous sys-
tem development [9–11]. We demonstrated that most
of the genes expressed in vitro were also expressed
during embryo development. However, there was no
specific enrichment of genes expressed in the central
nervous system (CNS).
MATERIALS AND METHODS
Cell culture and generation of the gene trap clones. MPI-II ES
cells [12] or R1 ES cells [13] were grown on mitomycin C (100 mg/ml,
Sigma, St. Louis, MO)-treated primary embryonic fibroblasts in Dul-
becco’s modified Eagle’s medium (DMEM 4.5 g glucose/l, GIBCO
BRL, Gaithersburg, MD) supplemented with 1 mM sodium pyruvate
(GIBCO BRL, Gaithersburg, MD), 1% of stock solution of nonessen-
tial amino acids (GIBCO BRL, Gaithersburg, MD), 2 mM L-glu-
tamine, 100 mmol b-mercaptoethanol, 500 U/ml leukemia inhibitory
factor (LIF, supplied by Amgene, Newbury Park, CA), and 20%
heat-inactivated fetal calf serum (FCS, selected batch from GIBCO
BRL, Gaithersburg, MD). Cells were regularly split every 2 days.
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Two gene trap vectors: pGT1.8geo (kindly provided by W. Skarnes
[14]) and pKC199bgeo [15] were used. They contained the splice
acceptor sequence from mouse En-2 or Hoxc9 gene fused to the
promoterless bgeo, which is a lacZ-neomycin phosphotransferase
fusion gene [4]. After electroporation and selection for 10 days by 250
mg/ml G418 (GIBCO BRL, Gaithersburg, MD), resistant clones were
isolated and stained with X-gal for the presence of b-galactosidase.
The positive clones were expanded and used for further analysis.
In vitro differentiation. In vitro differentiation of ES cells in
presence of RA and low level (1%) FCS was performed as described
previously [11]. ES cell clones showing b-galactosidase activity in
undifferentiated conditions were seeded onto a gelatin (0.1%)-coated
tissue culture dish. Cells were kept in full ES cell medium as de-
scribed above. After 2 days the cells were recovered by gentle
trypsinization (0.05% trypsin/EDTA solution) and cultured in sus-
pension for embryoid body preparation in DMEM medium with 1%
FCS. The embryoid bodies were treated for next 4 days with 1 mM all
trans-RA (Sigma, St. Louis, MO) prepared from a stock of 10 mM RA
in ethanol kept at 220°C in the dark. After 4 days of the suspension
culture the embryoid bodies were transferred to gelatin-coated cell
culture dishes with medium lacking RA, cultured for 5 days, and
stained with X-gal.
Production and analysis of chimeras. Chimeras were produced by
morula aggregation [12, 13]. Eight cell stage embryos (2.5-day embryos;
day of the plug 5 0.5) were recovered from superovulated and mated
NMRI or CD1 females. The zona pellucida was removed and embryos
were placed in a drop of M16 medium together with a clump of an
average of 10 ES cells for overnight culture. The resulting blastocysts
were transferred into the uterine horn of pseudopregnant recipient
females mated with vasectomized males 2.5 days before. 11.5-day chi-
meric embryos were recovered and stained in toto with X-gal. The
degree of chimerism was assessed by the pigmentation of the eye, and
for all clones more than one chimeric embryo was analyzed.
X-gal staining. Cultured cells or whole embryos were fixed in a
mixture of 2% formaldehyde and 0.2% glutaraldehyde in phosphate-
buffered saline (PBS), rinsed 3 times in PBS, and incubated over-
night at 37°C in a mixture of 1 mg/ml X-gal, 10 mM K3Fe(CN)6, 10
mM K4Fe(CN)6, and 2 mM MgCl2 in PBS. After incubation speci-
mens were washed in PBS for 24 h and then cleared in ascending
concentrations of glycerol in PBS up to 75%.
Statistical analysis. The correlation between gene expression in
vitro and in vivo was determined using the nonparametric McNe-
mare’s and Stewart’s test for dependent samples. The concordance
between two procedures was present if the differences between them
were shown to be random (P . 0.05).
RESULTS
To determine a correlation between gene expres-
sion in vitro, after RA-mediated embryoid body dif-
ferentiation, and in vivo, during embryo develop-
ment, 52 ES cell clones carrying gene trap insertion
within the genes expressed in undifferentiated ES
cells were analyzed. All of these clones were neomy-
cin resistant and had b-galactosidase activity in un-
differentiated cells. Each clone was simultaneously
processed for in vitro differentiation procedure and
for morula aggregation.
To preselect in vitro for genes expressed in the ner-
vous system, ES cells were differentiated by culturing
them in suspension in presence of 1 mM RA and low
level (1%) fetal calf serum. After 4 days of culture,
resulting embryoid bodies were plated to the adhesive
surface in the absence of RA. After attachment the
embryoid bodies gave rise to the colonies of differenti-
ated cells consisting of a central clump and a mono-
layer of peripheral cells. Neuronal processes were vis-
ible extending from the central clumps toward the
periphery (Figs. 1A and 1C).
The expression of genes captured by gene trap was
determined by X-gal staining of the embryoid body out-
growths 5 days after attachment. This was compared to
the gene expression in the corresponding 11.5-day chi-
meric embryos, determined by whole mount X-gal stain-
ing. Three main parameters were: ubiquitous gene ex-
pression, restricted expression, and no expression (Table
1A). After in vitro differentiation 14% of genes had ubiq-
uitous expression, 48% restricted, and 38% showed no
expression. In 11.5-day embryos corresponding genes
were in 30% of cases ubiquitously expressed, 35% re-
stricted, and 35% were not expressed.
When in vitro and in vivo gene expression was
compared, only 2 of 32 genes expressed after in vitro
differentiation were not expressed in 11.5-day em-
bryos. This concordance between in vitro and in vivo
system was statistically significant (differences P .
0.05; Table 1A). All genes ubiquitously expressed in
vitro, were also ubiquitous in vivo. However, not all
of the genes with restricted expression in vitro were
restricted in vivo. Nine of them were ubiquitously
expressed in 11.5-day embryos (Fig. 1A), and two of
them were not expressed at all. These differences
between two systems were statistically significant
(P , 0.01, Table 1A). Presuming that in vitro differ-
entiation of embryoid body outgrowths proceeds from
the periphery toward the center, and that the less
differentiated cells are present in the centre of the
outgrowths, we set apart the genes expressed only in
the central clumps from those expressed in the pe-
riphery as well (Table 1B; Figs. 1A–1C). When ex-
pression patterns were classified in this way, it was
possible to distinguish, according to in vitro expres-
sion, the genes expressed ubiquitously in vivo from
those not expressed at all. The concordance between
in vitro and in vivo expression was statistically sig-
nificant (differences P . 0.05). The genes with re-
stricted expression pattern in vivo showed three pos-
sibilities in vitro: restricted expression in the central
clumps and in the periphery, restricted expression
only in the central clumps, and no expression. The
highest number of clones belonged to the ‘‘central
clumps only’’ category (Fig. 1B).
To test the likelihood of in vitro preselection for
genes expressed during central nervous system
(CNS) development, the restricted expression pat-
terns in 11.5-day embryos were classified in two
groups: patterns including the CNS and those not
including CNS (Table 1C; Figs. 1D and 1E). From 18
genes expressed in restricted manner in 11.5-day
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embryos, two-thirds were expressed in CNS. When
compared with their expression after differentiation
in vitro, the genes were distributed through in vitro
categories regardless to their expression in the CNS
(Table 1C). The morphologically distinct neural cell
processes were present after differentiation, but only
two genes were expressed in cells having the pro-
cesses. These two genes were expressed in the CNS
in vivo, what we confirmed as well on tissue sections
(Figs. 1C and 1D).
DISCUSSION
The RA-mediated differentiation of embryoid bod-
ies generates from pluripotent ES cells a sizable
percentage of cells of the nervous tissue [9]. The
resulting neurons exhibit a number of neuronal
markers and possess the polarity and functional syn-
aptic transmission typical of CNS neurons [16, 17].
Other cell types, without morphologies as distinctive
as neuronal cells, differentiate as well. In this study
it was shown that genes expressed in different re-
gions of the embryo were expressed as well upon
RA-mediated embryoid body differentiation. This im-
plies that RA does not induce only neuronal genes in
vitro, but its effect is more general. However, this
conclusion is based on investigation of a sample from
a predefined group of genes, i.e., genes expressed in
undifferentiated ES cells. Thus all investigated
genes were expressed already before differentiation,
FIG. 1. (A–C) Embryoid body outgrowths after differentiation stained by X-gal; bar 100 mm. (D, E) 11.5-day embryos stained by X-gal; bar 1
mm. (A) In vitro expression of a gene, which is ubiquitously expressed in 11.5-day embryos. The expression is located within the central clump and
the periphery of the embryoid body outgrowth; arrow, neurite outgrowths. (B) In vitro expression of a gene, which is expressed in 11.5-day embryos
along the neural tube. The expression is confined to the restricted portions of the central clumps. (C, D) In vitro and in vivo expression of the same
gene. In vitro expression is located in the central clumps and in the outgrowth periphery. Gene was expressed in the neuron-like cells with long
cell process (arrows). The expression in 11.5-day embryos is located along the neural tube (arrowheads) and in the nasal region (double arrows).
(E) The expression pattern in the mesenchymal structures inside the embryo (arrows) not involving CNS. In vitro expression of the same gene was
present in restricted regions of the central clumps and the periphery of the embryoid body outgrowths.
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TABLE 1
Relationships between Gene Expression in Vitro and in Vivo
A In vitro pattern
Embryo pattern


















Total 16 18 18 52
B In vitro pattern
Embryo pattern






Central clumps and periphery 9 5 14
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Total 16 18 18 52










Central clumps and periphery 9 2 3 14
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Total 16 6 12 18 52
Note. Relationships between gene expression after RA-mediated differentiation of embryoid bodies and in the 11.5-day embryos. (A) Gene
expression is divided in three categories: ubiquitous expression, restricted expression, and genes not expressed. If ubiquitous and restricted
categories (four upper left fields) are combined together (i.e., expressed genes), there is a concordance between in vitro and in vivo system
(x2 5 0.66, df 5 1, P . 0.05). For the whole table, differences between these two systems are statistically significant (x2 5 9.66, df 5 2, P ,
0.01). (B) The same table with the restricted expressions in vitro divided in two categories: genes expressed in both the central clumps and
in the periphery of the embryoid body outgrowths, and those expressed only in the central clumps. (C) The previous table, but the embryo
patterns divided into those involving and not involving CNS (x2 5 0.98, df 5 3, P . 0.05).
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and no genes specifically activated by the treat-
ment could be taken into account. Consequently, it
is possible to conclude that RA induces in vitro
the expression of genes expressed in vivo in nonneu-
ral as well as in neural tissues. The genes not ex-
pressed in 11.5-day embryos are mostly turned off
in vitro.
It is obvious that the applied differentiation pro-
cedure used together with the gene trap could not
exclusively select for genes expressed in a restricted
manner during embryo development. However, it
could substantially increase the probability to obtain
such genes. The comparable efficiency was achieved
by an alternative strategy termed ‘‘induction gene
trap screen,’’ using RA treatment of undifferentiated
ES cells in order to select genes according to the
responsiveness to RA [18, 19]. Our approach differs
from the ‘‘induction screen’’ as it attempts to predict
the in vivo gene expression according to the expres-
sion pattern in differentiated cells. As a conse-
quence, most genes not expressed after in vitro dif-
ferentiation procedure were as well not expressed in
embryo, contrary to the genes repressed by RA dur-
ing the ‘‘induction screen,’’ which showed the re-
stricted expression pattern in embryo [18]. The final
gene trap strategy will depend on a specific task of
the particular investigator. It is certainly advisable
to combine in vitro differentiation procedure with
molecular characterization of the trapped gene and
the construct integration [8, 20, 21]. An additional
approach is to analyze the coexpression of specific
markers with the trapped genes [7, 8]. We checked
for genes expressed in cells with characteristic neu-
ron-like morphology and found two genes, which
were indeed expressed in the developing nervous
system.
The main advantage of the proposed differentia-
tion procedure is that it is rather simple and there-
fore can be applied to high number of ES cell clones.
One can even rely on simple monitoring of the gra-
dient of differentiation from the central clump to the
periphery of the embryoid body outgrowths. This can
be used in order to improve the current gene trap
approach in which only genes expressed in undiffer-
entiated ES cells are trapped. The RA-mediated dif-
ferentiation of embryoid bodies can be combined with
gene trap procedure where the neomycin resistance
will be driven by a constitutive promoter. This would
allow the screening for genes not expressed in undif-
ferentiated ES cells, but expressed specifically after
differentiation, a route which should target a new
group of developmentally important genes.
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